Dr Sunil Verma @cancermd Twitter profile

Last Seen Profiles

@0xFacet

@Plort

@shuitao626

@ruscaz

@jandakembangstw

@Paignton_Devon

@dd1201bb

@bokeplokalmalam

@tx_analysor

@StalkingVi96051

@RuhiziSandra

@Aisberg_aa

@stw46

@ThemBeforeUs

@BinorRaja

@bokeplokalmalam

@kondilati90

@WiggleWrig

@coffeecapi

@MdFaisa23215750

@jaerene33

@KimChenUm

@Karolconka

@yukobeauty0716

@THATSHITmcCRAY

@DIAMARKETPLACE

@TheSlavant

@sipotexxx

@ulili5

@katy_era

@uou_9o

@HepyHepy611818

@Pigrette2

@RajPanwar633123

@ProfeJander

@Marioscargo

Dr Sunil Verma

@cancermd

3 years

Today brings an exciting new chapter in my career, accepting the role of SVP, Global Head of Oncology, Medical. I am grateful to @AstraZeneca for this tremendous honor and opportunity and I’m looking forward to working together to eliminate Cancer as a cause of death.

112

12

715

Dr Sunil Verma

@cancermd

6 years

Easiest promotion committee decision ever!

As It Happens

@cbcasithappens

6 years

Breaking: Nobel Prize winner Donna Strickland has applied and been made a full professor @uwaterloo .

50

660

3K

7

43

426

Dr Sunil Verma

@cancermd

2 years

We woke up today to a new era in breast cancer treatment. I have never been more proud or grateful to be part of a transformative moment in cancer research. Most importantly, I look forward to seeing the new hope this brings for patients with cancer. #ASCO22

11

28

395

Dr Sunil Verma

@cancermd

3 years

We have lost an icon in Oncology today. His mentorship has guided many of us and he always brought the best in all of us. We will deeply miss his leadership, his brilliance and and his passion for bringing better therapies for patients. Jose, we will deliver on what you started.

6

28

313

Dr Sunil Verma

@cancermd

5 years

As we reflect upon the past decade and the remarkable advances in cancer care, please join me in thanking and acknowledging the thousands of cancer patients who participated and are participating in clinical trials to help improve outcomes now and in the future....THANK YOU!

8

72

316

Dr Sunil Verma

@cancermd

3 years

Super proud to be part of the journey in advancing the care of HER2-positive metastatic breast cancer. The scientific advancements at this year’s #ESMO21 are remarkable – and impact will be felt for decades to come. Missing my dear friend José Baselga, his legacy will live on.

14

15

284

Dr Sunil Verma

@cancermd

5 years

Thoughtful perspective by Dr Denis Slamon: “Patients participating in clinical trials are not subjects but our colleagues in cancer research” #ESMO19 @myESMO

5

70

241

Dr Sunil Verma

@cancermd

3 months

Day 1 in the new role, I am pleased to share that I am taking on a new role @AstraZeneca as SVP, Global Head, Oncology Franchise. In this role, I have the privilege of leading global teams bringing our cancer therapies to patients impacted by cancer with a focus on solid tumors

55

5

243

Dr Sunil Verma

@cancermd

5 years

Day 1 of a new chapter...thrilled to join @AstraZeneca family and excited to deliver on what science can do for our patients!

19

5

174

Dr Sunil Verma

@cancermd

2 years

I’m thrilled to be here at the White House this morning to kick off the National Breast Cancer Roundtable with @AmericanCancer . Looking forward to collaborating on how to accelerate progress for patients and truly honored to have the opportunity to contribute! #Cancermoonshot

5

4

168

Dr Sunil Verma

@cancermd

4 years

Important for all of us to reflect on the term 'negative' studies. We don't have negative studies - these studies can be just as biologically insightful and rich, practice informing, and provide us with guidance on how to move oncology research forward. #ESMO20

2

33

163

Dr Sunil Verma

@cancermd

5 years

Thank you @AstraZeneca @jsoriamd for this incredible opportunity. I look forward to working together with my colleagues, researchers, clinicians and most of all on behalf of patients as we shape the future of breast cancer care and research

soria

@jsoriamd

5 years

We @AstraZeneca are delighted that Dr. Sunil Verma will be joining the R&D Oncology organisation as Vice President, Head of Breast Cancer Strategy and Global Clinical Leader for DS-8201 in collaboration with Daiichi Sankyo

6

4

65

32

5

158

Dr Sunil Verma

@cancermd

3 months

23 years of ASCO in a row and more to come... Every year I start ASCO with a walk by the lake to reflect on what we have accomplished and what we need to do as a cancer community moving forward. Looking forward to meeting friends and colleagues from across the globe. #ASCO24

3

7

145

Dr Sunil Verma

@cancermd

5 years

Beautiful and elegant look at 40 years of breast cancer research and care and his own contributions by Dr Gabriel Hortobagyi, David Karnofsky Award Winner @ASCO #ASCO19

2

60

140

Dr Sunil Verma

@cancermd

5 years

I will forever be grateful to be given the opportunity to lead the Tom Baker Cancer Centre @AHS_CancerCare Department of Oncology @UCalgaryMed and start the build of new Calgary Cancer Centre. Thank you to the staff for your support and to our patients who will always inspire me!

5

6

137

Dr Sunil Verma

@cancermd

6 years

In clinic and was challenged by one of our patients on active chemo treatment to see if I can keep up with her in her spin class. Inspired by our patients, must admit I am intrigued and also quite sure that this won’t go well for me!

8

11

136

Dr Sunil Verma

@cancermd

3 years

As a Medical Oncologist, I’ve attended #SABCS for the past 20 years. It was a great first day at #SABCS21 to spend time with academic and clinical colleagues to learn of the unmet need and next wave of ideas to make even greater advances in breast cancer care - together.

2

1

127

Dr Sunil Verma

@cancermd

6 years

Here we go - arrived in San Antonio for the #SABCS18 meeting. Here is my top 10 list of key studies and some common themes to look for at this year's annual meeting @SABCSSanAntonio

0

48

119

Dr Sunil Verma

@cancermd

3 years

I am excited to announce that AZ Baselga Scholars Programme is now recruiting candidates. Jose's passion for drug development was the key driver as we shaped this together and we will integrate his lessons to develop the future leaders in drug development

2

22

117

Dr Sunil Verma

@cancermd

5 years

Dear friends, Please see note that I shared with staff @AHS_CancerCare and Dept @UCalgaryMed After 3+ yrs, I will be leaving my role here as of July '19. I will forever be grateful for this incredible opportunity and proud of our work together-I will continue to cheer you all on!

30

8

114

Dr Sunil Verma

@cancermd

3 years

As we join the #ASCO21 Breast cancer sessions, important to recognize that for 15% of patients diagnosed as TNBC we are still defining the cancer by what it’s not rather than what drives it. Let’s work together to better define and eliminate the term TNBC and then this disease.

1

17

108

Dr Sunil Verma

@cancermd

6 years

Congratulations to Dr Kathleen Pritchard on receiving the Order of Canada. Her contribution to field of breast cancer research has been exemplary and she has mentored a whole generation of Oncologists (including me) to help understand and design clinical trials that matter!

Gillian Hawker

@UofTDoMChair

6 years

A huge congratulations to Dr. Kathleen Pritchard, who has been invested into the Order of Canada today! 👏

1

4

39

1

24

109

Dr Sunil Verma

@cancermd

6 years

A tremendous achievement for breast cancer research and our patients. Six years after we published the results of T-DM1 for metastatic breast ca, the treatment has now shown to be effective for pts with high risk (residual disease post NAT) early stage breast ca #SABCS18 #bcsm

4

38

104

Dr Sunil Verma

@cancermd

3 years

Grateful to be part of the journey and research community that is transforming our understanding of Her2 biology that guides care. Transformation needs us to redraw the lines and reshape the foundation, we did that and soon hope to bring the next paradigm in breast cancer care.

2

8

100

Dr Sunil Verma

@cancermd

5 years

Brilliant presentation on role of ctDNA in detecting molecular relapse for early stage breast cancer by Nick Turner 1. Biology of breast cancer determined at initial diagnosis 2. Lead time (10mos) prior to clinical relapse 3. Consistent findings across all subtypes #ESMO19 #bcsm

0

35

92

Dr Sunil Verma

@cancermd

5 years

Broken Heart Broken Community Broken families It’s beyond words It’s beyond religion It’s beyond regions We have to heal together We have to act as one We have to see each other as one We are one....humanity

2

11

90

Dr Sunil Verma

@cancermd

6 years

Top 3( #bcsm ) from Day 2 #ESMO18 1.There is hope for IO in TNBC - benefit in PDL-1+ve pts only (IMpassion 130) 2.Alpha-Sp. PI3K-I effective in endo. Tx resistant MBC - new biomarker (SOLAR-1) 3.First mature OS for CDK4/6-I - PFS benefit extends to diff in OS (not Sig) (PALOMA-3)

1

34

86

Dr Sunil Verma

@cancermd

2 years

Day 1 of #ESMO22 and thrilled to be in Paris. Excited to be part of the oncology community as we present and discuss scientific advances. By working together, we can truly make a difference to patient care.

1

0

87

Dr Sunil Verma

@cancermd

6 years

Top 3 key ( #bcsm ) findings from Day 1 at #ESMO18 @myESMO 1. TILs may predict pts who can be offered a shorter duration of adj Tras (SHORT-HER) 2. Low risk patients (<T2,N0) have similar benefit with 9w vs. 1yr (SHORT-HER) 3. 16% of pre-menop. pts are non-adherent to endo Tx at 1y

5

56

84

Dr Sunil Verma

@cancermd

7 years

Significant progress in Cancer survival rates for most cancers over past three decades ...

3

63

85

Dr Sunil Verma

@cancermd

2 years

I’m grateful to ⁦⁦ @ASCOPost ⁩ for sharing my career journey. It is a privilege to work with and be inspired by so many incredible people who are driven by science and needs of patient care. It’s been an honor to once again be amongst you at #ASCO22

Sunil Verma, MD, Navigates an International Path From Clinical Educator in Oncology to Leadership...

In this installment of The ASCO Post’s Living a Full Life series, guest editor, Jame Abraham, MD, spoke with Sunil Verma, MD, the Global Head of Oncology, Medical, at AstraZeneca.

ascopost.com

13

9

84

Dr Sunil Verma

@cancermd

4 years

Wonderful to see the Google search page commemorating Terry Fox today. An important reminder of how much we learn and need to learn from the courage and strength of our Cancer patients.

0

13

82

Dr Sunil Verma

@cancermd

6 years

Telling slide - just depends where we set the bar for non-inferiority..what is an acceptable margin? Markedly consistent results but different conclusions! #SABCS18

4

34

80

Dr Sunil Verma

@cancermd

4 years

Brilliant article, heartbreaking and real. Wuhan-the largest manufacturing site for masks; Lombardy-largest manufacturing site for NP swabs,unreal how this story is being written and when+how will Science outpace the virus. How Will the Coronavirus End?

3

35

76

Dr Sunil Verma

@cancermd

2 years

I am excited to be here at #SABCS22 as this is my 20th year attending it! This has always been a special congress at the end of the year to share hope for the new year and a new future for patients with breast cancer. Looking forward to meeting colleagues from across the globe!

3

1

77

Dr Sunil Verma

@cancermd

2 years

Thrilled to have landed in Chicago for #ASCO22 – grateful to share developments that will transform science to patient care, anticipate and deliver the next wave of therapies and connect with colleagues from around the world with one mission … to improve patient care.

4

0

75

Dr Sunil Verma

@cancermd

3 years

José is looking down on us, cheering us. His promise of being Cancer’s Fiercest Opponent is realized today. We are transforming breast cancer the way he always wanted us to transform the disease. Bringing more out of us (and out of our medicines) – the way he always envisioned.

Dr Sunil Verma

@cancermd

3 years

Super proud to be part of the journey in advancing the care of HER2-positive metastatic breast cancer. The scientific advancements at this year’s #ESMO21 are remarkable – and impact will be felt for decades to come. Missing my dear friend José Baselga, his legacy will live on.

14

15

284

3

6

74

Dr Sunil Verma

@cancermd

3 years

Missing not seeing friends and colleagues at #ESMO21 The congress always has a special place in my heart and miss not being there in person in Paris. Wishing all an enjoyable virtual experience @myESMO

0

3

73

Dr Sunil Verma

@cancermd

5 years

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial - The Lancet ⁦ @TheLancet ⁩

2

23

69

Dr Sunil Verma

@cancermd

2 years

Proud to be present here with @JustinTrudeau as we share an important milestone announcing our investment in growing @AstraZenecaCA R&D hub, remarkable opportunities for the incredible talent across Canada.

2

67

Dr Sunil Verma

@cancermd

6 years

Wonderful news for #TNBC pts with this approval. But still many Qs remain unanswered:1. Is the benefit specific with just combo with nab-paclitaxel? 2. Do we have the right biomarker (PDL-1 on IC)? 3. Which line of Tx? 4. Magnitude of OS benefit? 5. Tx effect beyond TNBC in #Bcsm

FDA Oncology

@FDAOncology

6 years

FDA grants accelerated approval to atezolizumab (TECENTRIQ®, Genentech Inc.) in combination with paclitaxel protein-bound for adult patients with unresectable locally advanced or metastatic triple-negative breast cancer whose tumors express PD-L1

0

53

77

4

20

68

Dr Sunil Verma

@cancermd

3 years

Here @expo2020dubai with @GlopesMd discussing Global cancer efforts to #collab4healthierworld

1

3

68

Dr Sunil Verma

@cancermd

3 years

There have been several great advances in the treatment of breast cancer over the last two decades. At #ESMO21 we will see the dawn of what’s next, as we work relentlessly together to offer renewed hope for our patients #bcsm

1

7

65

Dr Sunil Verma

@cancermd

5 years

Wishing all a very Merry Christmas and Happy Holidays. Remember to take care of yourself and each other!

1

66

Dr Sunil Verma

@cancermd

6 years

Thank you Premier @RachelNotley and Minister @SANDRAYYCNW for visiting our Cancer Centre and seeing the progress. Kudos to @PCLConstruction and all the health care workers who are guided by our patients and caregivers to build this wonderful facility #BuildingHope

AHS_CancerCare

@AHS_CancerCare

6 years

⁦ @RachelNotley ⁩ is joined by Cancer Control Alberta executives ⁦ @cancermd ⁩ as well as Dr Parliament and Nancy Guebert as well as Minister Jansen to celebrate the continued progress of the Calgary Cancer Centre

0

15

29

0

19

62

Dr Sunil Verma

@cancermd

5 years

Brilliant discussion by Dr Angelo DiLeo on the improvement in OS seen in Monaleesa-7 trial with a focus on prior endocrine Tx and primary vs secondary resistance #ASCO19

0

25

63

Dr Sunil Verma

@cancermd

5 years

Great work ⁦ @FAndreMD ⁩ Genomic characterization of metastatic breast cancers | Nature (So impressive to have ⁦ @NEJM ⁩ @nature publications and playing soccer with stars in the same week..trifecta!)

Genomic characterization of metastatic breast cancers

Nature - Patient data from six clinical trials are used to compare the genomic landscapes of breast cancer metastases with those of primary tumours, revealing an increase in mutational burden and...

www.nature.com

0

12

62

Dr Sunil Verma

@cancermd

6 years

Key Qs as we start #ESMO18 1. Role of IOs in TNBC (IMPASSION 130)? 2. Are we ready for a new biomarker i.e. pI3K (SOLAR-1)? 3. Are CDK4/6-Is assoc. with improved OS and if so for which pts. (PALOMA-3)? 4. Who can we consider for 6m of adj. Trastuzumab (PERSEPHONE and SHORT-HER)?

0

24

60

Dr Sunil Verma

@cancermd

6 years

IMPassion 130- randomized study of Atezolizumab + nab-paclitaxel vs NP alone in 1st line mTNBC. Results: ITT - PFS 7.2m v 5.5m ; PDL-1 +ve (41%) PFS 5m v 7.5m OS 15.5m v 25m (descriptive only) First positive study of IO in TNBC #ESMO18

2

27

61

Dr Sunil Verma

@cancermd

6 years

Wonderful news for our Triple Negative Breast Cancer patients and field of Immunotherapy research in Breast Cancer. First Phase III trial of IO in TNBC - First line Nab-Paclitaxel +/- Atezo: Positive for PFS (IMPASSION 130 Study). Await to see the magnitude of difference #bcsm

1

26

63

Dr Sunil Verma

@cancermd

7 years

Great summary slide by Dr Ingrid M - impact of CDK4/6-Is in MBC #ASCO17

0

45

61

Dr Sunil Verma

@cancermd

6 years

TAILORx abstract released by @ASCO > 6500 pts with intermediate RS of 11-25 randomized to endocrine tx vs Chemo + ET. ET was non-inferior to CET for iDFS (HR 1.08)Median f/up of 90m. A remarkable effort by @jsparano - look forward to plenary today #ASC018

0

39

62

Dr Sunil Verma

@cancermd

3 months

An amazing, historic and unforgettable @ASCO Wonderful to see colleagues from across the globe with a shared passion to progress Cancer research and care. #ASCO24

3

6

62

Dr Sunil Verma

@cancermd

3 years

We are making great strides for patients with metastatic breast cancer to help improve outcomes. We must continue raising the bar with more effective therapies. I am proud to be part of the team @AstraZeneca that is developing the future of breast cancer care #bcsm

4

61

Dr Sunil Verma

@cancermd

5 years

Majestic Canadian Rockies...will miss you lots! #SunshineMeadows

1

3

59

Dr Sunil Verma

@cancermd

7 years

On this #WorldCancerDay let us acknowledge the bravery and courage of our patients as they face this disease; those who are no longer with us but have taught us many lessons; the incredible staff at our centres; and the hope that the research brings to our patients #WeCanICan

0

13

55

Dr Sunil Verma

@cancermd

6 years

#ASCO18 Abstracts came out today - here are my top 5 for Breast Cancer @ASCO @ASCOPost

2

30

59

Dr Sunil Verma

@cancermd

1 year

Good morning to all those at #ASCO23 Looking forward to meeting with many of you from across the globe. It is such a special meeting, 22 years in a row for me (not including those two pandemic years!). Immerse in science and research as it sets the path for care advances to come.

0

57

Dr Sunil Verma

@cancermd

3 years

Inspiring and emotional day today as we watched the premiere of documentary on José Baselga–a titan in the field who transformed Cancer care. He was a friend and inspired many in Oncology community. His legacy will live on through our work. Stream now:

1

13

56

Dr Sunil Verma

@cancermd

5 years

As millions around the world celebrate the Festival of Lights Diwali, May we all shine our inner light to illuminate ourselves and those around us and reflect on the true meaning of this festival to mark light over darkness and good over evil. #HappyDiwali

1

5

58

Dr Sunil Verma

@cancermd

6 years

Wishing friends and colleagues a very Happy New Year! May we all continue to listen to and serve our patients, be inspired to do better by their needs, collaborate and learn from each other around the world

5

6

57

Dr Sunil Verma

@cancermd

6 years

Two important Negative Phase II studies were presented at the Poster discussion session (should have been considered for general session). Lots to learn: 1.Continuous Palbociclib (vs approved dosing schedule) doesn’t improve PFS 2. No Benefit of IO Tx with T-DM1 #SABCS18

1

26

56

Dr Sunil Verma

@cancermd

6 years

It has been a pivotal month for Her 2 research/Tx 1. T-DM1>Herceptin in the adjuvant setting (residual disease post neoadjuvant) -Katherine trial- Breakthrough designation by FDA (Feb 2019) 2. NALA Study: Cape+Neratinib > Cape + Lap imp PFS and now 3. SOPHIA Margetux>Tras imp PFS

Aditya Bardia, MD

@dradityabardia

6 years

Metastatic HER2 breast cancer: Positive results from phase 3 SOPHIA Study of Margetuximab, monoclonal HER2 Ab, vs trastuzumab (HR=0.76, p=0.033). If approved, might be a potential option - post THP, T-DM1 ⁦ @hoperugo ⁩

0

13

27

2

16

54

Dr Sunil Verma

@cancermd

4 years

Frontlines: We think of you As you march through each door With courage and purpose With knowledge and care Driven to help one and all In times that we haven’t imagined We support and salute you This will pass but your effort will be recognized and remembered Now and forever

2

9

57

Dr Sunil Verma

@cancermd

2 years

Good morning Chicago! To all those attending #ASCO22 have wonderful Congress, stay safe and may you continue to learn and advance Cancer research forward!

1

0

57

Dr Sunil Verma

@cancermd

6 years

SOLAR-1 Trial (PI3-k Inh. Alpelisib in Metastatic Breast Cancer) met primary endpont of PFS. Key things to look when data is reported(likely #ESMO18 ): 1. Toxicity profile 2. Magnitude of diff. in PFS 3. Efficacy in CDK4/6 tx patients 4. PI3k test profile

SOLAR-1 trial of Novartis investigational alpha-specific PI3K inhibitor BYL719 (alpelisib) meets...

www.novartis.com

1

24

54

Dr Sunil Verma

@cancermd

4 years

Things I have learned over the past 48 hours - 1. different permutations and combinations to reach 270 2. Names of all counties in GA, PA, AZ and NV and 3. John King doesn’t need much sleep

3

2

55

Dr Sunil Verma

@cancermd

6 years

Congratulations to @DrDanielHeng as he takes on Medical Lead position for our Clinical Research Program at Tom Baker Cancer Centre. He is internationally recognized for his research efforts in GU Ca. In this role, he will help to strengthen+grow clinical trials @AHS_CancerCare

2

8

53

Dr Sunil Verma

@cancermd

4 years

An informative pictorial by ⁦ @MackayIM ⁩ - We all have a role and responsibility in stopping the spread... it’s on all of us to do our part.

3

20

53

Dr Sunil Verma

@cancermd

4 years

No lost luggage No long cab rides No early 6am meetings No badges needed All access a click away Virtual #ASCO20 .. I like it like that!

4

55

Dr Sunil Verma

@cancermd

4 years

Powerful images - Italian comic illustrator Milo Manara finds new heroes — women on the front lines of the coronavirus pandemic - The Washington Post

1

20

52

Dr Sunil Verma

@cancermd

5 years

ASCO Announces Top Studies to Be Presented at 2019 Annual Meeting | ⁦ @ASCO ⁩ #ASCO19

ASCO Announces Top Studies to Be Presented at 2019 Annual Meeting

Cancer experts from around the world will gather to share the latest clinical cancer research impacting patient care at the 55th Annual Meeting of the American Society of Clinical Oncology (ASCO).

society.asco.org

0

22

54

Dr Sunil Verma

@cancermd

6 years

So pleased to have Dr. Doreen Ezeife @DoreenEzeife and Dr. Steven Yip @Yipilimumab join the Tom Baker Cancer Centre Medical Oncology group @AHS_CancerCare @UCalgaryMed I am sure you will excel in clinical and academic domains!

2

1

54

Dr Sunil Verma

@cancermd

5 years

Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence | Clinical Cancer Research

2

20

53

Dr Sunil Verma

@cancermd

6 years

Acquired HER2 mutations in ER + metastatic breast cancer confer resistance to estrogen receptor–directed therapies | Nature Genetics ⁦ @nature ⁩ | By ⁦ @Nikhilwagle ⁩ Team

Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor–di...

Nature Genetics - Activating HER2 mutations are shown to confer resistance to ER-directed therapies in patients with ER+ metastatic breast cancer. Drug resistance caused by HER2 mutations was...

www.nature.com

0

17

53

Dr Sunil Verma

@cancermd

5 years

HER2 and Breast Cancer — A Phenomenal Success Story | ⁦ @NEJM ⁩ ...terrific read by ⁦ @hoosierdfh ⁩

HER2 and Breast Cancer — A Phenomenal Success Story | NEJM

The 2019 Lasker–DeBakey Clinical Medical Research Award goes to scientists whose work on the human epidermal growth factor receptor 2 in breast cancer launched a new era in clinical research and th...

www.nejm.org

0

20

52

Dr Sunil Verma

@cancermd

3 years

#InternationalWomenAndGirlsInScienceDay I would like to acknowledge the mentorship from pioneers - Drs Kathy Pritchard and Maureen Trudeau @Sunnybrook and @lillian_siu and grateful to work with and learn from great colleagues @HornLeora @ndenduluri1 @susanmgalbraith @ruth_march

2

4

51

Dr Sunil Verma

@cancermd

5 years

The St Gallen International Consensus Guidelines for the Primary Therapy of Early Breast Cancer 2019 | Annals of Oncology | ⁦ @Annals_Oncology ⁩ Great work ⁦ @curijoey ⁩ ⁦ @DrHBurstein ⁩ #weekendreads

2

16

52

Dr Sunil Verma

@cancermd

2 years

Great to be back in Vienna for #WCLC22 At @AstraZeneca we are committed to advancing lung cancer care to help an even greater number of people with lung cancer. We are proud to share our latest advances at this congress in collaboration with the clinical and scientific community.

0

2

53

Dr Sunil Verma

@cancermd

4 years

Feels odd not flying to San Antonio #SABCS20 breaking a continuous streak since ‘03. It was always great to end year seeing colleagues from around the world. While not the same, look to connect virtually next week to share hope for better therapies for our breast cancer patients.

0

53

Dr Sunil Verma

@cancermd

6 years

Wonderful and Insightful words for all of us to consider and reflect upon as we discuss advances at #ESMO18 by Sir William Osler: “...the person who takes medicine must recover twice, once from the disease and once from the medicine” (slide courtesy from @FallowfieldLJ ) @myESMO

0

20

51

Dr Sunil Verma

@cancermd

8 years

Congrats to @Nikhilwagle and patients contributing to the #mbcproject @DanaFarber - your work helps us all! #sabcs16

0

21

51

Dr Sunil Verma

@cancermd

6 years

SOLAR-1: Randomized Phase 3 Study of Alpelisib (alpha-specific PI3k- Inhibitor) + Fulvestrant vs Fulvestrant alone. Results: PI3k mutation +ve PFS: 5.7m vs 11.0 m. Tox: Increased hyperglycemia (36% Grade3/4) and rash (10% Grade 3) #ESMO18

2

17

48

Dr Sunil Verma

@cancermd

4 years

Humanity We see it all around us We see it in the eyes even if we can’t see the face We see it in the numbers even if they frighten us We see it in the stories even if we don’t know them We see it in the actions even if we don’t see the hands that serve We see it in each other

0

8

50

Dr Sunil Verma

@cancermd

5 years

Thank you @ASCO for hosting us and kudos to the tremendous staff planning the #ASCO19 meeting, a very impressive team!

Amanda Narod

@AmandaBinDC

5 years

#ASCO19 is getting real! Packed house of @ASCO volunteers planning the scientific program. @ASCOPres theme: Caring for Every Patient, Learning from Every Patient

2

4

47

1

6

50

Dr Sunil Verma

@cancermd

1 year

Thank you @ASCO for another outstanding #ASCO23 congress, great to meet colleagues from around the globe. Cancer research is driven by these important collaborations.

0

1

48

Dr Sunil Verma

@cancermd

1 year

Great to kick off #AACR23 with the AACR fellows inductee ceremony. Congratulations to the inductees, it is a testament to your tremendous contribution to Cancer research. Looking forward to AACR congress starting today, a view into the next generation of medicines.

2

0

50

Dr Sunil Verma

@cancermd

5 years

Landed in Berlin, @myESMO save me a seat #ESMOBreast19 Excited to discuss two pivotal oral presentations on optimizing HER2 positive and HER3 positive breast cancer #bcsm

ESMO - Eur. Oncology

@myESMO

5 years

Meanwhile, back in #Berlin , preparations are starting 🙂Safe travels to those attending, see you tomorrow! #ESMOBreast19 @curijoey

0

3

23

1

6

48

Dr Sunil Verma

@cancermd

6 years

The reason why #ESMO18 is in mid-October this year. Munich may look a little different when the oh so boring Oncologists show up!

4

3

45

Dr Sunil Verma

@cancermd

6 years

We reached another important milestone for the design and build of the new Calgary Cancer Centre. So very proud and appreciative of the support and engagement from staff and teams @AHS_CancerCare @AHS_YYCZone @UCalgaryMed Thanks @PCLConstruction for your partnership #buildinghope

1

11

47

Dr Sunil Verma

@cancermd

6 years

May I suggest #SLIFIE - the moment when everyone wants to take that pic of a slide - in most cases never to be looked at or used again #researchpaparazzi

Sam Blackman

@drsam

6 years

We need to come up with a name for the phenomenon of dozens or hundreds of iPhone/iPad/camera holding hands coming up simultaneously every time a new slide is put up by a speaker. It's a science version of #TheWave . But needs a better name. #AACR18

27

30

157

7

13

47

Dr Sunil Verma

@cancermd

5 years

Congratulations @DrDanielHeng We @AHS_CancerCare @UCalgaryMed are so proud of you! This is such a well deserved recognition of your achievements. We know you made this happen while mentoring the next generation of oncologists, which makes it even more special.

Kidney Cancer Canada

@KidneyCancer_Ca

5 years

We wish @DrDanielHeng all the best tomorrow as he is recognized with the Meritorious Service Cross for his leading work in the field of #kidneycancer at Rideau Hall. We are very proud.

6

15

72

2

4

46

Dr Sunil Verma

@cancermd

3 months

Energized and grateful to be part of the Oncology community bringing hope for a brighter future in Cancer care @ASCO24 @ASCO

1

3

46

Dr Sunil Verma

@cancermd

6 years

#WorldCancerDay #IAmAndIWill : listen to and serve my patients; never forget those who have passed away from Cancer; work and collaborate with researchers and clinicians across the globe to prevent cancer and advance cancer care and educate + mentor the nxt generation

0

12

46

Dr Sunil Verma

@cancermd

3 years

Thanks @ASCO for making the #ASCO21 experience so seamless and effective. We miss being in person, but you have delivered to help us all engage and share advances in Cancer research. Thank you🙏

0

3

44

Dr Sunil Verma

@cancermd

7 years

The design is incredible and beyond that what makes the inside even more remarkable is our cancer staff!

AHS_CancerCare

@AHS_CancerCare

7 years

An exciting day for #Alberta and #cancer ! The new Calgary Cancer Centre design was unveiled, find out what's inside

0

25

48

2

12

44

Dr Sunil Verma

@cancermd

6 years

A terrific day for lung cancer patients and field of lung cancer research. The role of an ideal biomarker to provide an individualized approach is necessary to integrate these therapies in routine care #AACR18 via @NEJM

0

15

43

Dr Sunil Verma

@cancermd

6 years

So very well deserved @TonyMok9 Tony, I think you still have one more lifetime of work that will help our lung cancer patients and the field of oncology. @myESMO better be ready to give you another one in a few years!

ESMO - Eur. Oncology

@myESMO

6 years

Tony Mok given ESMO Lifetime Achievement Award 2018 for his practice changing contribution to #lungcancer @TonyMok9

1

12

38

0

8

44

Dr Sunil Verma

@cancermd

4 years

Wishing Canada a very Happy Birthday! You get better every year and continue to shine even more. Missing celebrating with you this year, can’t wait to see you soon. #CanadaDay2020 🇨🇦

1

0

45

Dr Sunil Verma

@cancermd

5 years

Arrived in BCN...Wishing everyone a safe, productive and enlightening #ESMO19

ESMO - Eur. Oncology

@myESMO

5 years

#ESMO19 : Barcelona is a safe city but also known for the risk of minor crimes such as pickpocketing. The Barcelona police force gives the following safety advice when attending a congress 👇👇

2

19

29

3

42